High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$14.0M
$13,953,300
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| TNGX |
Tango Therapeutics, Inc.
|
President
Other
|
2026-04-01 | $140,400 | M | Form 4 |
| TNGX |
Tango Therapeutics, Inc.
|
President
10b5-1 SellΔOwn -19.3%
|
2026-04-01 | $572,478 | S | Form 4 |
| TNGX |
Tango Therapeutics, Inc.
|
President
10b5-1 Sell
|
2026-03-25 | $241,320 | S | Form 4 |
| TNGX |
Tango Therapeutics, Inc.
|
President
Other
|
2026-03-25 | $62,400 | M | Form 4 |
| TNGX |
Tango Therapeutics, Inc.
|
President
10b5-1 SellΔOwn -15.2%
|
2026-03-05 | $303,765 | S | Form 4 |
| TNGX |
Tango Therapeutics, Inc.
|
President
10b5-1 SellΔOwn -29.0%
|
2026-02-25 | $694,208 | S | Form 4 |
| TNGX |
Tango Therapeutics, Inc.
|
President
Sell to Cover
|
2026-02-03 | $223,708 | S | Form 4 |
| TNGX |
Tango Therapeutics, Inc.
|
CFO
Sell to Cover
|
2026-02-03 | $125,073 | S | Form 4 |
| TNGX |
Tango Therapeutics, Inc.
|
CFO
Sell to Cover
|
2026-02-03 | $1,457 | S | Form 4 |
| TNGX |
Tango Therapeutics, Inc.
|
Chair
Sell to Cover
|
2026-02-03 | $369,999 | S | Form 4 |
| TNGX |
Tango Therapeutics, Inc.
|
Chair
Sell to Cover
|
2026-02-03 | $4,295 | S | Form 4 |
| TNGX |
Tango Therapeutics, Inc.
|
President
Sell to Cover
|
2026-02-03 | $2,592 | S | Form 4 |
|
TNGX
S
Tango Therapeutics, Inc.
Third Rock Ventures IV, L.P.
• 10% Owner
Discretionary Sell
2025-10-23
$4,846,575Large
|
||||||
| TNGX |
Tango Therapeutics, Inc.
|
10% Owner
Discretionary Sell
|
2025-10-23 | $4,846,575Large | S | Form 4 |
|
TNGX
S
Tango Therapeutics, Inc.
Third Rock Ventures IV, L.P.
• 10% Owner
Discretionary Sell
2025-09-25
$4,008,500Large
|
||||||
| TNGX |
Tango Therapeutics, Inc.
|
10% Owner
Discretionary Sell
|
2025-09-25 | $4,008,500Large | S | Form 4 |
|
TNGX
S
Tango Therapeutics, Inc.
Third Rock Ventures IV, L.P.
• 10% Owner
Discretionary Sell
2025-09-16
$2,559,329Large
|
||||||
| TNGX |
Tango Therapeutics, Inc.
|
10% Owner
Discretionary Sell
|
2025-09-16 | $2,559,329Large | S | Form 4 |